The clinical FTD syndrome is a heterogenous cluster of neurodegenerative disorders classified into broad subgroups according to pathological criteria; nearly half of FTD patients have a proteinopathy called frontotemporal lobe degeneration‐tau (FTLD‐Tau) [2]. Here, MAPT is linked to proteostasis deficiencies.